Broncus Holding Corporation

Research Broncus Holding Corporation (2216.HK) on Bullrun: market cap HKD 337.33M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is HKD 337.33M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2024USD 8.13M-USD 15.30M-USD 10.32M75.5%-0.03USD 46.47MUSD 318.00KUSD 169.48M
FY2023USD 10.26M-USD 28.09M-USD 26.84M70.5%-0.06USD 83.56MUSD 2.36MUSD 185.37M
FY2022USD 9.41M-USD 28.04M-USD 31.81M77.7%-0.06USD 106.76MUSD 1.47MUSD 213.46M
FY2021USD 10.89M-USD 235.78M-USD 33.38M80.3%-0.79USD 227.21MUSD 1.95MUSD 242.42M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18HKD 337.33Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 HKD.

About Broncus Holding Corporation

Broncus Holding Corporation, a medical device company, focuses on the development and commercialization of interventional pulmonology medical devices in China and internationally. The company offers InterVapor, a thermal vapor treatment system to treat chronic obstructive pulmonary disease (COPD); BroncAblate Radiofrequency Ablation System, a transbronchial interventional treatment product for lung cancer;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Broncus Holding Corporation's market cap?

Broncus Holding Corporation's market capitalization is HKD 337.33M.

What does Broncus Holding Corporation do?

Broncus Holding Corporation, a medical device company, focuses on the development and commercialization of interventional pulmonology medical devices in China and internationally.